Skip to content

Application of mild Indian Laburnum Alkali and medicated Indian Laburnum oil tampon for the treatment of Swelling, ulcer and discharge on cervix.

A Randomized Open Labelled Controlled Clinical Study To Evaluate The Efficacy Of Aragvadha Pratisaraneeya Mridu Kshara And Aragvadha Taila Pichu In The Management Of karnini Yonivyapat With Special Reference To Cervical Erosion. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090172
Enrollment
30
Registered
2025-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri

Interventions

None listed

Sponsors

Dr Padhma Sree M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 20 to 50 years and married. 2.Subjects with Cervical Erosion on Per Speculum examination. 3.Patients suffering from classical symptoms of Karnini Yoni Vyapat like Karnika, Yonigata Srava, and Yoni Kandu. 4.Patients suffering from classical symptoms of Cervical Erosion like vaginal discharge, post coital bleeding, dyspareunia, features of cervicitis like pelvic pain, backache, burning micturition. 5.Subjects who are fit for Kshara karma.

Exclusion criteria

Exclusion criteria: 1.Subjects who are unmarried, pregnant and lactating. 2.Subject who had undergone Cryosurgery, Thermal cauterization, Loop electrosurgical excision procedure (LEEP). 3.Subjects on Intra Uterine Contraceptive Device (IUCD), Hormonal Pills, Alcohol, smoking, Drug abuse. 4.Subjects with Acute Pelvic Inflammatory Disease (PID). 5.Subject with Known case of Pre-malignant and Malignant lesions of Cervix and other organs. 6.Subjects with known case of Congenital Anomalies, Psychiatric Disorders, severe Systemic Illness, STDs and HIV. 7.Subjects who are Kshara Karma Anarha. 8.Subjects who are not willing to sign the consent form.

Design outcomes

Primary

MeasureTime frame
Significant decrease in Cervical Erosion and its signs and symptoms based on subjective and objective parameters. Timepoint: Significant decrease in Cervical Erosion and its signs and symptoms based on subjective and objective parameters with in 7 days

Secondary

MeasureTime frame
Generation of in - depth analysed data on the different aspect of the disease. Generation of data on possible unexpected drug reaction. Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Rajani Kagga

Sri Sri College Of Ayurvedic Science and Research

drcrajanii@gmail.com9739766448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026